This inventor holds 1 USPTO granted patent. Top assignee: The Center for the Improvement of Human Functioning, International, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Nina Mikarova: Innovator in Metabolic Dysfunction Detection
Introduction
Nina Mikarova is a notable inventor based in Wichita, Kansas, recognized for her groundbreaking work in the field of metabolic dysfunction detection. With a focus on utilizing fluorescence emission from serum, her innovative approach aims to enhance the diagnosis and treatment of various metabolic disorders.
Latest Patents
Mikarova holds a patent for her invention titled "Detection of metabolic dysfunctions using fluorescence emission from serum." This method allows for the detection of metabolic disorders in mammals by analyzing changes in serum emission. The invention has shown significant potential in identifying conditions such as cancer, thyroid disorders, arthritis, diabetes, coronary artery disease, hypertension, chronic fatigue syndrome, and fibromyalgia. The correlation between serum emission levels and energy metabolism provides a valuable tool for risk assessment and treatment monitoring.
Career Highlights
Mikarova is affiliated with the Center for the Improvement of Human Functioning, International, Inc., where she continues to contribute to advancements in health and wellness. Her work emphasizes the importance of early detection and intervention in metabolic health, showcasing her commitment to improving patient outcomes.
Collaborations
Mikarova has collaborated with esteemed colleagues, including Hugh D. Riordan and Paul Rillema, to further her research and enhance the impact of her innovations in the medical field.
Conclusion
Nina Mikarova's contributions to the detection of metabolic dysfunctions represent a significant advancement in medical diagnostics. Her innovative methods have the potential to transform how metabolic disorders are identified and managed, ultimately improving the quality of life for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile